This was NephJC’s first Tweetorial. We hope to make these regular components of the content NephJC generates to describe and disseminate the latest research.
Should we call 2024 the Renaissance of nephrology? It was probably the richest year in RCTs in the nephrology world, reflected in the higher number of Late-Breaking Clinical Trials sessions at every big nephrology congress. Probably 1st place won’t surprise anyone; it was the anticipated FLOW of the year, but this Top 10 Nephrology Stories definitely includes some unexpected titles
This was NephJC’s first Tweetorial. We hope to make these regular components of the content NephJC generates to describe and disseminate the latest research.
1/ #Tweetorial #NephJC #Hypernatremia Reviews and guidelines say to correct hypernatremia in adults by no more than 10 mmol/L per day. This is based on little hard data, has little support in literature and may be harmful https://t.co/OlZHsSyHX1 pic.twitter.com/MZOBqgwZ40
— Nephrology Jrnl Club (@NephJC) May 15, 2019